Cargando…

The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids

Detalles Bibliográficos
Autores principales:	Shokri, Somayeh, Mahmoudvand, Shahab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986273/ https://www.ncbi.nlm.nih.gov/pubmed/35398269 http://dx.doi.org/10.1016/j.aohep.2022.100704

Ejemplares similares

Effect of Lactate on Epigenetic Regulation in the Development of Hepatitis B Virus-related Hepatocellular Carcinoma
por: Mahmoudvand, Shahab, et al.
Publicado: (2022)

Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
por: Mahmoudvand, Shahab, et al.
Publicado: (2019)

Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran
por: Makvandi, Manoochehr, et al.
Publicado: (2022)

Is it possible to eradicate the covid-19 or not?
por: Khezri, Rozhan, et al.
Publicado: (2022)

Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment
por: Mahmoudvand, Shahab, et al.
Publicado: (2021)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Disseminated aspergillosis in an immunocompetent patient treated with corticosteroids: value of PCR for diagnosis
por: Guirao-Arrabal, Emilio, et al.
Publicado: (2019)

Vitamin C and corticosteroids in viral pneumonia
por: Anstey, Matthew Harry, et al.
Publicado: (2021)

Answers to the comments on “air born possibility of covid19 virus”
por: Vosoughi, Mehdi, et al.
Publicado: (2021)

Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
por: John, Teny M., et al.
Publicado: (2020)

The association between corticosteroid uses and mortality among severe COVID-19 patients
por: Tang, Hung-Jen, et al.
Publicado: (2021)

Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19
por: Foo, Hong, et al.
Publicado: (2023)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

SUCCESSFUL TREATMENT OF SEVERELY CHOLESTATIC ACUTE HEPATITIS B WITH ORAL CORTICOSTEROID
por: MALLICK, Bipadabhanjan, et al.
Publicado: (2020)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021)

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020)

Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Jung, Jiwon, et al.
Publicado: (2020)

Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate
por: Chaudhry, Zain, et al.
Publicado: (2021)

Do corticosteroids have a role in treating Ebola virus disease?
por: Xu, Jun, et al.
Publicado: (2014)

Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
por: Kim, Jani M., et al.
Publicado: (2022)

Selective C‐reactive protein apheresis for Covid‐19 patients suffering from organ damage
por: Kayser, Stefan, et al.
Publicado: (2020)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
por: do Carmo, Rodrigo Feliciano, et al.
Publicado: (2022)

What can we learn about corticosteroid therapy as a treatment for COVID-19?
por: Tang, J.
Publicado: (2020)

A case of shock after 10 days systemic corticosteroid therapy for COVID-19
por: Uemura, Keiko, et al.
Publicado: (2021)

Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy
por: Crisan-Dabija, Radu, et al.
Publicado: (2021)

Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients
por: Talan, Leyla, et al.
Publicado: (2022)

Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19
por: Fu, Qibo, et al.
Publicado: (2020)

Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications
por: Sica, Rossella, et al.
Publicado: (2021)

Reactivation of Bovine Tuberculosis in Patient Treated with Infliximab, Switzerland
por: Nager, Marina, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1niedu2ukk4cv5uor598dcdudc